Concepedia

Saravanan Parthasarathy

SP

2

Publications

35

Citations

2

H-Index

2018

Active since

Affiliations

Eli Lilly (United States)(Current)

Saravanan Parthasarathy is an author at Eli Lilly (United States) specializing in drug discovery, pharmacology, and medicine.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryBiophysicsPharmacotherapyDrug DevelopmentNatural SciencesMolecular DockingMedicinal Chemistry

Publications per year

2018–2022

2

Publications

2

Paradoxical Increase of Permeability and Lipophilicity with the Increasing Topological Polar Surface Area within a Series of PRMT5 Inhibitors

Upendra A. Argikar, Markus Blatter, Dallas Bednarczyk et al. · Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

Proteinlipid Interaction, Limited Passive Permeability, Pharmaceutical Science +16

Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT

Saravanan Parthasarathy, Kenneth J. Henry, Huaxing Pei et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 16 citations · Full text

Medicinal Chemistry, Chiral Dihydropyridopyrimidinones, Pharmaceutical Science +11

Rows per page

1–2 of 2